DE602006010061D1 - Malariaimpfstoffe - Google Patents

Malariaimpfstoffe

Info

Publication number
DE602006010061D1
DE602006010061D1 DE602006010061T DE602006010061T DE602006010061D1 DE 602006010061 D1 DE602006010061 D1 DE 602006010061D1 DE 602006010061 T DE602006010061 T DE 602006010061T DE 602006010061 T DE602006010061 T DE 602006010061T DE 602006010061 D1 DE602006010061 D1 DE 602006010061D1
Authority
DE
Germany
Prior art keywords
combination
epitope
sequence
containing sequences
malaria vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006010061T
Other languages
English (en)
Inventor
Kevin K A Tetteh
David J Conway
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
London School of Hygiene and Tropical Medicine
Original Assignee
London School of Hygiene and Tropical Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by London School of Hygiene and Tropical Medicine filed Critical London School of Hygiene and Tropical Medicine
Publication of DE602006010061D1 publication Critical patent/DE602006010061D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/23—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a GST-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE602006010061T 2005-05-27 2006-05-26 Malariaimpfstoffe Active DE602006010061D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0510763.6A GB0510763D0 (en) 2005-05-27 2005-05-27 Malaria vaccines
PCT/GB2006/050126 WO2006126029A2 (en) 2005-05-27 2006-05-26 Malaria vaccines

Publications (1)

Publication Number Publication Date
DE602006010061D1 true DE602006010061D1 (de) 2009-12-10

Family

ID=34834684

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006010061T Active DE602006010061D1 (de) 2005-05-27 2006-05-26 Malariaimpfstoffe

Country Status (7)

Country Link
US (2) US20090196884A1 (de)
EP (1) EP1888625B1 (de)
AT (1) ATE446970T1 (de)
DE (1) DE602006010061D1 (de)
ES (1) ES2334706T3 (de)
GB (1) GB0510763D0 (de)
WO (2) WO2006126030A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180348218A1 (en) * 2017-06-05 2018-12-06 Tokitae Llc Serology assay for recent malaria infection
EP3861007A4 (de) * 2018-10-01 2022-07-13 United Neuroscience Gegen dipeptid-repeat-proteine aus c9orf72 gerichtete peptid-immunogen-konstrukte

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1025244A2 (de) * 1997-10-20 2000-08-09 Genzyme Transgenics Corporation Neue modifizierte msp-1 nukleinsäuresequenzen und verfahren zur erhöhung der mrna-niveau und der proteinexpression in zellsystemen

Also Published As

Publication number Publication date
WO2006126029A3 (en) 2007-04-12
ES2334706T3 (es) 2010-03-15
WO2006126030A3 (en) 2007-03-29
GB0510763D0 (en) 2005-06-29
US20140093530A1 (en) 2014-04-03
US20090196884A1 (en) 2009-08-06
EP1888625B1 (de) 2009-10-28
ATE446970T1 (de) 2009-11-15
WO2006126029A2 (en) 2006-11-30
EP1888625A2 (de) 2008-02-20
WO2006126030A2 (en) 2006-11-30

Similar Documents

Publication Publication Date Title
TW200621287A (en) Vaccines
DE60142689D1 (de) Verwendung prokariotischer pest-ähnlicher peptide zur verstärkung der immunogenität von antigenen
WO2007016185A3 (en) Mono-and bi-functional antibody conjugates as effective adjuvants of protein vaccination
ATE318899T1 (de) Fusionsproteine, die stressproteine beinhalten, zum hervorrufen einer immunantwort
EA200700849A1 (ru) Первичная/бустерная противомалярийная вакцина
EA201992434A1 (ru) Новые противомалярийные вакцины и антитела, связывающиеся со спорозоитами плазмодия
BRPI0708344B8 (pt) vetores adenovirais quiméricos e composição imunogênica
DK1963361T3 (da) Multimere komplekser af antigener og c4bp
EA200900738A1 (ru) Слитые белки, содержащие антигены отторжения опухоли ny-eso-1 и lage-1
DE69520943T2 (de) Malariapeptide
DE602006010061D1 (de) Malariaimpfstoffe
ATE362378T1 (de) Verfahren und zusammensetzungen zur bildung einer schützenden immunantwort gegen malaria
WO2007020520A3 (en) Antigenic peptides and their use
WO2005014654A3 (en) Product comprising a c4bp core protein and a monomeric antigen, and its use
EA201200538A1 (ru) Арабиногалактан для повышения приобретенного иммунного ответа
DK1697405T3 (da) LSA-5 leverstadium- og blodstadium-antigen fra Plasmodium falciparum, immunogent præparat omfattende dette antigen samt vacciner mod malaria
ATE404152T1 (de) Pathogene impstoffe und verfahren zur deren verwendung
CU23553A1 (es) Péptidos que mimetizan las regiones antigénicas del virus de la hepatitis a
WO2005007691A8 (en) East coast fever vaccine based on ctl-specific schizont antigens
FR2839721B1 (fr) Antigene polypeptidique induisant des anticorps neutralisant le vih
Lozano et al. Towards a poly-functional synthetic-antimalarial vaccine: Incorporating non-natural elements into artificially-made peptides for mimicking functional pathogen ligand structures representing new site-directed vaccine components
BRPI0924581A2 (pt) seqüências geneticamente modificadas de antígenos de plasmodium vivax, composições vacinais contendo proteínas recombinantes e vírus recombinantes que expressam esses antígenos e método de vacinação dose-reforço contra malária
AR052027A1 (es) Peptidos adyuvantes de vacunas mucosales, composicion de vacuna que lo comprende, proteina quimerica, uso para la preparacion de vacunas y metodo para incrementar la respuesta inmune
FR2868319B1 (fr) Antigene tat dimerique et ses applications pour la vaccination anti-vih
TH98092A (th) วัคซีนสำหรับมาลาเรีย

Legal Events

Date Code Title Description
8364 No opposition during term of opposition